当前位置: X-MOL 学术Nat. Biotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Convalescent plasma falls flat in first randomized trial.
Nature Biotechnology ( IF 33.1 ) Pub Date : 2020-09-24 , DOI: 10.1038/d41587-020-00020-0
Cormac Sheridan

Plasma from individuals who have recovered from COVID-19 could benefit sick patients, but definitive evidence for or against convalescent plasma is still lacking. A consensus about how it should be deployed is beginning to emerge—and tools and insights to guide its use are becoming available.

中文翻译:


在第一项随机试验中,恢复期血浆表现持平。



来自 COVID-19 康复者的血浆可以使病人受益,但仍然缺乏支持或反对恢复期血浆的明确证据。关于如何部署它的共识正在开始出现,并且指导其使用的工具和见解也正在变得可用。
更新日期:2020-09-24
down
wechat
bug